The House Energy and Commerce Subcommittee on Health voted Wednesday in favor of sending legislation that would authorize the FDA to track individual medication to the full committee for consideration. The measure aims to stop counterfeit treatments from reaching consumers and would fix supply-chain loopholes. The measure "will help ensure that counterfeit or stolen drugs do not enter the supply chain and harm patients," said Rep. Joe Pitts, R-Pa. "It will also ensure that overlapping red tape does not impose dramatic costs on patients in the form of higher prescription-drug costs or potential drug shortages."

Full Story:
Hill, The

Related Summaries